Yorktown Management & Research Co Inc boosted its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 105.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,100 shares of the construction company's stock after acquiring an additional 22,600 shares during the quarter. Yorktown Management & Research Co Inc owned 0.05% of Aspen Aerogels worth $524,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in ASPN. Sargent Investment Group LLC boosted its position in Aspen Aerogels by 14.7% in the 4th quarter. Sargent Investment Group LLC now owns 371,049 shares of the construction company's stock valued at $4,723,000 after buying an additional 47,680 shares during the last quarter. Greenwood Capital Associates LLC increased its position in Aspen Aerogels by 5.0% in the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock worth $439,000 after purchasing an additional 1,749 shares during the period. Journey Strategic Wealth LLC bought a new stake in Aspen Aerogels during the 4th quarter worth about $178,000. Perigon Wealth Management LLC lifted its position in Aspen Aerogels by 66.8% during the 4th quarter. Perigon Wealth Management LLC now owns 34,451 shares of the construction company's stock valued at $433,000 after purchasing an additional 13,796 shares during the period. Finally, Ballentine Partners LLC boosted its stake in shares of Aspen Aerogels by 19.2% in the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock valued at $189,000 after purchasing an additional 2,565 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.
Aspen Aerogels Stock Down 1.2 %
ASPN stock traded down $0.15 during mid-day trading on Friday, hitting $11.49. 1,068,583 shares of the company were exchanged, compared to its average volume of 1,390,847. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The firm has a market cap of $942.34 million, a P/E ratio of 1,149.65 and a beta of 2.14. The firm's 50 day simple moving average is $12.50 and its 200 day simple moving average is $18.87. Aspen Aerogels, Inc. has a 1-year low of $10.67 and a 1-year high of $33.15.
Analyst Ratings Changes
ASPN has been the subject of a number of recent research reports. Roth Mkm dropped their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a research note on Friday, November 8th. HC Wainwright reissued a "buy" rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Saturday. Piper Sandler cut their target price on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. Finally, Canaccord Genuity Group decreased their target price on Aspen Aerogels from $28.00 to $20.00 and set a "buy" rating for the company in a research report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $29.11.
Read Our Latest Stock Analysis on Aspen Aerogels
About Aspen Aerogels
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Further Reading

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.